CDC37 Monoclonal antibody

CDC37 Monoclonal Antibody for WB, IF, ELISA

Host / Isotype

Mouse / IgG2a


human, mouse, rat







Cat no : 66420-1-Ig


CDC37, CDC37A, Hsp90 co chaperone Cdc37, P50CDC37

Tested Applications

Positive WB detected inHeLa cells, HEK-293 cells, MCF-7 cells, Jurkat cells, ROS1728 cells, RAW 264.7 cells, NIH/3T3 cells
Positive IF detected inHeLa cells

Recommended dilution

Western Blot (WB)WB : 1:2000-1:5000
Immunofluorescence (IF)IF : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Published Applications

IFSee 1 publications below

Product Information

66420-1-Ig targets CDC37 in WB, IF, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman
Host / Isotype Mouse / IgG2a
Class Monoclonal
Type Antibody
Immunogen CDC37 fusion protein Ag0267
Full Name cell division cycle 37 homolog (S. cerevisiae)
Calculated Molecular Weight 44 kDa
Observed Molecular Weight 44 kDa
GenBank Accession NumberBC000083
Gene Symbol CDC37
Gene ID (NCBI) 11140
Conjugate Unconjugated
Form Liquid
Purification MethodProtein A purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

CDC(cell division control) family of proteins are regulatory proteins involved in the processes of cell cycle and proliferation. CDC37, migrated as a protein of 50 kDa in SDS PAGE, is a co-chaperone protein that recruits several immature client kinases to Hsp90 for proper folding. It functions in association with Hsp90, although little is known of its mechanism of action or where it fits into a folding pathway involving other Hsp90 cochaperones. CDC37 up-regulation is a common early event in some localized human cancers. But, the effect of CDC37 dysregulation in human cells is unclear.


Product Specific Protocols
WB protocol for CDC37 antibody 66420-1-IgDownload protocol
IF protocol for CDC37 antibody 66420-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols



Acta Pharmacol Sin

Okicamelliaside targets the N-terminal chaperone pocket of HSP90 disrupts the chaperone protein interaction of HSP90-CDC37 and exerts antitumor activity.

Authors - Chuan-Jing Cheng